Bavarian Nordic: "We are ready to buy more vaccines"

In recent years, the Danish drugmaker has acquired vaccines for both commercialization and development ­ this could very well happen again, according to CFO Henrik Juuel.
Photo: Pool/Reuters/Ritzau Scanpix
Photo: Pool/Reuters/Ritzau Scanpix
by mikkel aabenhus hemmingsen & christian bundgaard, translated by daniel pedersen

As orders keep coming for Bavarian Nordic’s monkeypox vaccine, the Danish drugmaker has restated its ambition to become one of the world’s biggest vaccine companies.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must contain at least 6 characters
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading